Advances in medical research, made during the last few decades, have improved the prophylactic, diagnostic and therapeutic capabilities for variety of infections/diseases. However, many of the prophylactic and therapeutic procedures have been seen in many instances to exact a price of host-vulnerability to an expanding group of opportunistic pathogens and yeasts are one of the important members in it. Fortunately amongst the vast majority of yeasts present in nature only few are considered to have the capability to cause infections when certain opportunities predisposes and these are termed as ‘opportunistic pathogenic yeasts.’ However, the term ‘pathogenic’ is quite tricky, as it depends of various factors of the host, the ‘bug’ and the environment to manifest the clinical infection. The borderline is expanding. In the present century with unprecedented increase in number of immune-compromised host in various disciplines of health care settings, where any yeast, which has the capability to grow at 37 ° C (normal body temperature of human), can be pathogenic and cause infection in particular situation
Spectrum of infective yeasts varies in different geographical region and mainly depends upon nature of immune suppression of the patients and prevailing yeast in the environment. Opportunistic yeast pathogen mostly reported are Candida spp. (albicans, tropicalis, krusei, parapsilosis, kefyr, glabrata, dubliensis, rugosa and others), Cryptococcus neoformans (var grubii,var neoformans and var gattii), Trichosporon spp. and occasionally others like Geotrichum spp, Pichia spp. etc
Among these, C. albicans has been regarded as the most common agent of invasive yeast infection
The population of patients at risk has expanded to include those with a broad list of medical conditions, such as solid-organ and hematopoietic stem cell transplantation (HSCT), cancer, receipt of immunosuppressive therapy, HIV/AIDS, premature birth, advanced age, and major surgery. Furthermore, the etiology of these infections has changed. In the 1980s, yeasts (particularly Candida albicans) were the most common causative agents of invasive mycoses. However, presently non albi-cans species of Candida (NAC) account for > 50 % of infections. In addition, infections caused by other yeasts, such as Trichosporon species, have been reported. This chapter intends to high light important predisposing factors responsible for increase incidence of opportunistic yeast infection, its clinical significance, diagnostic approach for early detection of pathogenic yeast, guide line of therapy and epidemiology of important opportunistic yeast pathogen specially that of Candida and Cryptococcus
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Advani, S.H., Kochupillai, V., Lalitha, N., Shanta, S., Maitreyan, V., Nair, R., Banerjee, U., Kelkar, R., and Mukherjee, S. 1996. J. Assoc. Phys Ind. 44: 764–73.
Aggarwal, O.P., Sharma, A.K., and Inddrayan, A. 1997. HIV/AIDS Research in India, Ministry of Health and Family Welfare, Government of India, New Delhi, pp. 713–720.
Almirante B., Rodríguez, D., Cuenca-Estrella, M., Almela, M., Sanchez, F., Ayats, J., Alonso-Tarres, C., Rodriguez-Tudela, J.L., and Pahissa, A. 2006. The Barcelona Candidemia Project Study Group. J. Clin. Microbiol. 44: 1681–1685.
Alspaugh, J.A., Perfect, J.R., and Heitman, J. 1997. Gene Dev. 11: 3206–3217.
Banerjee, U., Gupta, K., and Venugopal, P. 1997. J. Med. Vet. Mycol. 35: 139–141.
Banerjee, U. 2005. Indian J. Med. Res. 121: 395–406.
Banerjee, U., Chatterjee, B., Kapil, A., and Sethi, S. 1992. Abstract. XVI National Congress of Medical Microbiologists, New Delhi, India, P32a: 144.
Banerjee, U., Datta, K., and Casadavell, A. 2004. Med. Mycol. 42: 181–186.
Banerjee, U., Dutta, K., Diwedi, M., and Sethi, S. 2001. Nat. J. Infect. Dis. 2: 32–36.
Banerjee, U., Gupta, K., and Sethi, S. 1994. Nat. Med. J. Ind. 1: 51–53.
Banerjee, U., Jain, N. and Prasad, K.N. 2005. Trends in Medical Mycology (TIMM), October 2005, Germany (Abstract)
Banerjee, U., Khadka, J.B., Sethi, S. and Gupta, K. 1995. Ind. J. Med. Res. 102: 272–274.
Banerjee, U., Saha, D.C., and Sethi, S. 2001a. 25th Annual Congress of Indian Association of Medical Microbiologists, All India Institute of Medical Sciences New Delhi. Abstract No 251: p. 272.
Banerjee, U., Dutta, K., Majumdar, T., and Gupta, K. 2001b. Med. Mycol. 39: 51–67.
Barnett, J.A., Payne, R.W., and Yarrow, D. 1983. Yeasts: Characteristics and Identification. Cambridge University Press, Cambridge.
Beynon, R.P., Bahl, V.K., and Prendergast, B.D. 2006. BMJ 333: 334–339.
Burnie, J.P., Odds, F.C., Lee, W., Webster, C., and Williams, J.D. 1985. BMJ 290: 746–748.
Casadevall, A. and Perfect, J.R. 1998. Cryptococcus neoformans. Washington DC: ASM Press, pp. 407–408.
Casadevall, A., and Pirofski, L.A. 2002. Ann. Med. 34: 2–4.
Chakrabarty, A., Jatana, M., Kumar, P., Chatha, L., Kaushal, A., and Padhye, A.A. 1997. J. Clin. Microbiol. 35: 3340–3342.
Chignell, A.H. 1992. J. R. Soc. Med. 85: 721–724.
Colombo, A.L., Nucci, M., Salomao, R., Branchini, M.L., Richtmann, R., Derossi, A. and Wey, S.B. 1999. Diagn. Microbiol. Infect. Dis. 34: 281–286.
Datta, K., Jain, N., Sethi, S., Rattan, A., Casadavell, A., and Banerjee, U. 2003. J Antimicrob. Chemother. 52: 683–686.
Denning, D.W., Stevens, D.A., and Hamilton, J.R. 1990. J.Clin. Microbiol. 28: 2565–2567.
Diamond, R.D. 1990. In: Principles of infectious diseases. (Eds. Mandell, G.L., Douglas, R.G. and Bennett, J.E.). New York: Churchill Livingstone, pp. 1980-–1989.
Drouhet, E.J. Mycol. Med.1997. 7: 10–27.
Fatkenheuer, G., Buchheidt, D., Cornely, O.A., Fuhr, H.G., Karthaus, M., Kisro J., Leithauser, M., Salwender, H., Sudhoff, T., Szelenyi, H., and Weissinger, F. 2003. Ann. Hematol. 82(Suppl. 2): S149–157.
Fidel, P.L. Jr., Vazquez, J.A. and Sobel, J.D. 1999. Clin. Microbiol. Rev. 12: 80–96.
Fotedar, R. and Banerjee, U., 1996. J. Inf. 3: 243–245.
Goswami, R. Dadhwal, V., Tejswi, S., Datta, K., Paul, A., Haricharan, R.N., Banerjee, U., and Kochupillai, N.P. 2000. J. Infect. 41: 162–166.
Goswami, D., Goswami, R., Banerjee, U., Dadhwal, V., Miglani, S., and Latiff, A.A. Kochupillai. 2006. N.J. Infec. 52: 111–117.
Guiterrez, J. 2002. J. Basic Microbiol. 3: 207–227.
Hall, W.J. 1980. J. R. Soc. Med. 73: 567–569.
Handa, R., Banerjee, U., Gupta, K., Singh, M.K., Singh, H., and Wali, J.P. 1996. J Assoc Phys Ind. 44: 348.
Hoper, R.L., Walden, P., Setterquist, S., and Highsmit, W.E. 1993. J. Med. Vet. Mycol. 31: 65–67.
Huffnagle, K.E. and Gander, R.M. 1993. J. Clin. Microbiol. 31: 419–421.
Jagarlamudi, R., Kumar, L., Kochupillai, V., Kapil, A., Banerjee, U., and Thulkar, S. 2000. Med. Oncol. 17: 111–116.
Jain, N., Li L., Diane, M.C., Banerjee, U., Cook, E., Wang, X., and Fries, B.C. 2006. Infect. Immunity 74: 896–903.
Jain, N., Wickes, B.L., Keller, S.M., Fu, J., Casadevall, A., Ragan, M.A., Banerjee, U., and Fries, B.C. J. Clin. Microbiol.2005. 43: 5733–5742.
Kojic, E.M., and Darouiche, R.O. 2004. Clin. Microbiol. Rev. 17: 255–267.
Kralovicova, K., Spanik, S., Oravcova, E., Mrazova, M., Morova, E., Gulikova, V., Kukuckova, E., Koren, P., Pichna, P., Nogova, J., Kunova, A., Trupl, J., and Krcmery, V. Jr. 1997. Scand. J. Infect. Dis. 29: 301–304.
Krcmery, V. and Barnes, A.J. 2002. J. Hosp. Infect. 2002. 50: 243–260.
Kumarasamy, N., Solomon, S., Jayaker Paul, S.A., Venilla, R., and Amalraj, R.E. 1995. Int. J. STD AIDS 6: 447–449.
Kwon-Chung, K.J., and Bennett, J.E. 1984. Am. J. Epidemiol. 120: 123–130.
Kwon-Chung, K.J., and Bennett, J.E. 1992. Medical Mycology. Philadelphia: Lea and Fabiger, pp. 397–445.
Lattiff, A.A., Banerjee, U., Prasad, R., Biswas, A., Wig, N., Sharma, N., Haque, A., Gupta, N., Baquer, N.Z., and Mukhopadhyay, G. 2004. J. Clin. Microbiol.1260–1262.
Leleu, G., Aegerter, P., and Guidet, B. 2002. J. Crit. Care 17: 168–175.
Maenza, J.R., W.G., Merz, M. J., Romagnoli, J.C., Keruly, R.D., Moore, J.E., and Gallant. 1997. Clin. Infect. Dis. 24: 1204–1207.
Mandal, P., Banerjee, U., Casadevall, A., and Nosanchuck, J.D. 2005. J. Clin. Microbiol. 43: 4766–4772.
Marques, S.A., Robles, A.M., Tortorano, A.M., Tuculet, M.A., Negroni, R., and Mendes, R.P. 2000. Med. Mycol.–38: 269–279.
Mitchell, T.G., Freedman, E.Z., White, T.J., and Taylor, J.W. 1994. J. Cin. Microbiol. 32: 253–255.
Mirdha, B.R., Banerjee, U., Sethi, S., Samantaray, J.C., and Malviya, A. 1993. CARC Calling 6: 9–10.
Mirdha, B.R., Maheshwari, M.C., Sethi, S., Dan, G., and Banerjee, U. 1998a. Ind. Paed. 35: 360–363.
Mirdha, B.R., Sethi, S., and Banerjee, U. 1998b. Ind. J. Med. Res. 107: 91–93.
Musial, C.E., Cockerill, F.R., 3rd Roberts, G.D. 1988. Clin. Microbiol. Rev. 1: 349–364.
Nguyen, M.H., Nguyen, M.L., Yu, V.L., Mc. Mahon, D., Keys, T.F., and Amidi, M. 1996. Clin. Infect. Dis. 22: 262–267.
Nguyen, M.H., Peacock, J.E., Morris, A.J., Tanner, D.C., Nguyen, M.L., Snydman, D.R., Wagener, M., Rinaldi, M.G., and Yu, V.L. 1996. Am. J. Med. 100: 617–623.
Odds, F.C. 1988. Candida and Candidiasis: A Review and Bibliography,2Bailliere Tindall, Toronto, Ontario, Canada.
Peer, A.K., Hoosen, A.A., Seedat, M.A., van den Ende, J., and Omar, M.A. 1993. S. Afr. Med. J. 83: 727–729.
Pfaller, M.A. 1996. Nosocomial Candidiasis. Clin. Infect. Dis. 22(Suppl. 2): S89–S94.
Pfaller, M.A., Jones, R.N., Doern, G.V., Sader, H.S., Messer, S.A., Houston, A., Coffman, S., Hollis, R.J. and The SENTRY Participant Group 2000. Antimicrob. Agents Chemother. 44: 747–751.
Polachek, I. 1991. Int. J. Med. Microbiol. 276: 120–123.
Ramos, J.M., Cuenca-Estrella, M., Gutierrez, F., Elia, M., and Rodriguez-Tudela, J.L. 2004. J. Clin. Microbiol. 42(5): 2341–2344.
Rastogi, A, Datta, K., Paul, A., Sethi, S., and Banerjee, U. 1999. Nat. J. Inf. Dis. 1: 33–35.
Reed, B.D. 1992. Obstet. Gynecol. Surv. 47: 551–560.
Rippon, J.W. 1988. Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes. 3 The WB Saunders Co., Philadelphia, pp. 532–558.
Seidenfeld, S.M., Lemaistre, C.F., Setiawan, H., and Munford, R.S. 1982. J. infect. Dis. 146: 569.
Sood, S., Majumdar, T., Chatterjee, B., Sethi, S., Dutta, K., and Banerjee, U. 1998. Mycoses 41: 417–419.
Solomon, S., and Ganesh, A.K. 2002. HIV in India, International AIDS Society—USA 10: 19–24.
Staib, F., Seibold, M., Antweiler, E., Forhlich, B., Weber, S., and Blisse, A. 1987. Hyg. A. 266: 167–177.
Strinden, W.D., Helgerson, R.B., and Maki, D.G.. 1985. Ann. Surg. 202: 653–658.
Tortorano, A.M., Caspani, L., Rigoni, A.L., Biraghi, E., Sicignano, A., and Viviani, M.A. J. Hosp.2004. Infect. 57: 8–13.
US Public Health Service/Infectious Disease Society of America. Guidelines for prevention of opportunistic infections in persons infected with the human immunodeficiency virus. 1995. Morb. Mort. Week Rep. 44(RR-8): 1.
Vilgalys, R., and Hester, M. 1990. J. Bacteriol. 172: 4238–4246.
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., Pauw, D.B., and Meunier, F. 1999. Clin. Infect. Dis. 28: 1071–1079.
Wingard, J.R. 1995. Clin. Infect. Dis. 20: 115–125.
World Health Organization. 2001. Guidelines on Standard Operating Procedure for Laboratory Diagnosis of HIV- Opportunistic Infections 2001. (Ed. Kumari, S.), New Delhi.
Yang, Y.L., Cheng, H.H., Ho, Y.A., Hsiao, C.F., and Lo, H.J. 2003. J. Microbiol. Immunol. Infect. 36: 187–191.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media B.V
About this chapter
Cite this chapter
Banerjee, U. (2009). Opportunistic Pathogenic Yeasts. In: Satyanarayana, T., Kunze, G. (eds) Yeast Biotechnology: Diversity and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8292-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-4020-8292-4_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-8291-7
Online ISBN: 978-1-4020-8292-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)